Content about Protonix

February 21, 2012

Nearly $1 billion in damages asserted in lawsuit over GERD drug

A division of Pfizer is asserting that it incurred nearly $1 billion in damages related to the launch of generic versions of one of its drugs.

February 10, 2011

Actavis OKed to market generic Protonix

Actavis has received approval from the Food and Drug Administration to market a generic version of a popular gastroesophageal reflux disease treatment.

January 24, 2011

Matrix Labs' generic Protonix DR receives FDA approval

The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday.